PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Conditions
Refractory Solid Tumors · Relapsed Solid Tumors · Relapsed Neuroblastoma · Refractory Neuroblastoma · Relapsed Rhabdomyosarcoma · Refractory Rhabdomyosarcoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Cedars-Sinai Medical Center, Los Angeles, California, United States
Contact: Principal Investigator (Leo Mascarhenhas, MD)University of California, San Francisco, San Francisco, California, United States
Contact: Principal Investigator (Jennifer Michlitsch, MD)Boston Children's Hospital, Boston, Massachusetts, United States
Contact: Principal Investigator (David Shulman, MD)Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Principal Investigator (David Shulman, MD)Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Contact: Principal Investigator (Jacquelyn Crane, MD)Texas Children's Hospital, Houston, Texas, United States
Contact: Principal Investigator (Jennifer Foster, MD)University of Utah Hospital, Salt Lake City, Utah, United States
Contact: Principal Investigator (Matthew Dietz, MD)
Study leads
Jacquelyn Crane, MD
Principal Investigator
Children's Hospital of Philadelphia